John Rolfe is the co-founder of Argand Capital Advisors LLC, an investment advisor, and the portfolio manager of Candela Capital LP, a private investment fund focused on quality-driven event-based value investing. He has over fifteen years of investing and transaction structuring experience, in... More
FDA today removed a bunch of Pernix Therapeautics' products from the market. Appears that the removals include products from both Brovex and Aldex lines. Unclear at this point how much a revenue hit this will represent to PTX. Relevant news links:
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.
View John Rolfe's Instablogs on:
FDA removed Pernix products from market
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm245048.htm
http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/SelectedEnforcementActionsonUnapprovedDrugs/ucm245106.htm